• Something wrong with this record ?

Anthracyclines and their metabolism in human liver microsomes and the participation of the new microsomal carbonyl reductase

A. Skarka, L. Skarydová, H. Stambergová, V. Wsól,

. 2011 ; 191 (1-3) : 66-74.

Language English Country Ireland

Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

Anthracyclines (ANTs) are widely used in the treatment of various forms of cancer. Although their usage contributes to an improvement in life expectancy, it is limited by severe adverse effects-acute and chronic cardiotoxicity. Several enzymes from both AKR and SDR superfamilies have been reported as participants in the reduction of ANTs. Nevertheless all of these are located in the cytosolic compartment. One microsomal reductase has been found to be involved in the metabolism of xenobiotics-11beta-HSD1, but no further information has been reported about its role in the metabolism of ANTs. The aim of this study is to bring new information about the biotransformation of doxorubicin (DOX), daunorubicin (DAUN) and idarubicin (IDA), not only in human liver microsomal fraction, but also by a novel human liver microsomal carbonyl reductase that has been purified by our group. The reduction of ANTs at C-13 position is regarded as the main pathway in the biotransformation of ANTs. However, our experiments with human liver microsomal fraction show different behaviour, especially when the concentration of ANTs in the incubation mixture is increased. Microsomal fraction was incubated with doxorubicin, daunorubicin and idarubicin. DOX was both reduced into doxorubicinol (DOXOL) and hydrolyzed into aglycone DOX and then subsequently reduced. The same behaviour was observed for the metabolism of DAUN and IDA. The activity of hydrolases definitely brings a new look to the entire metabolism of ANTs in microsomal fraction, as formed aglycones undergo reduction and compete for the binding site with the main ANTs. Moreover, as there are two competitive reducing reactions present for all three ANTs, kinetic values of direct reduction and the reduction of aglycone were calculated. These results were compared to previously published data for human liver cytosol. In addition, the participation of the newly determined human liver microsomal carbonyl reductase was studied. No reduction of DOX into DOXOL was detected. Nevertheless, the involvement in reduction of DAUN into DAUNOL as well as IDA into IDAOL was demonstrated. The kinetic values obtained were then compared with data which have already been reported for cytosolic ANTs reductases.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12027903
003      
CZ-PrNML
005      
20121207104723.0
007      
ta
008      
120817s2011 ie f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.cbi.2010.12.016 $2 doi
035    __
$a (PubMed)21185270
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Skarka, Adam $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Hradec Kralove, Czech Republic.
245    10
$a Anthracyclines and their metabolism in human liver microsomes and the participation of the new microsomal carbonyl reductase / $c A. Skarka, L. Skarydová, H. Stambergová, V. Wsól,
520    9_
$a Anthracyclines (ANTs) are widely used in the treatment of various forms of cancer. Although their usage contributes to an improvement in life expectancy, it is limited by severe adverse effects-acute and chronic cardiotoxicity. Several enzymes from both AKR and SDR superfamilies have been reported as participants in the reduction of ANTs. Nevertheless all of these are located in the cytosolic compartment. One microsomal reductase has been found to be involved in the metabolism of xenobiotics-11beta-HSD1, but no further information has been reported about its role in the metabolism of ANTs. The aim of this study is to bring new information about the biotransformation of doxorubicin (DOX), daunorubicin (DAUN) and idarubicin (IDA), not only in human liver microsomal fraction, but also by a novel human liver microsomal carbonyl reductase that has been purified by our group. The reduction of ANTs at C-13 position is regarded as the main pathway in the biotransformation of ANTs. However, our experiments with human liver microsomal fraction show different behaviour, especially when the concentration of ANTs in the incubation mixture is increased. Microsomal fraction was incubated with doxorubicin, daunorubicin and idarubicin. DOX was both reduced into doxorubicinol (DOXOL) and hydrolyzed into aglycone DOX and then subsequently reduced. The same behaviour was observed for the metabolism of DAUN and IDA. The activity of hydrolases definitely brings a new look to the entire metabolism of ANTs in microsomal fraction, as formed aglycones undergo reduction and compete for the binding site with the main ANTs. Moreover, as there are two competitive reducing reactions present for all three ANTs, kinetic values of direct reduction and the reduction of aglycone were calculated. These results were compared to previously published data for human liver cytosol. In addition, the participation of the newly determined human liver microsomal carbonyl reductase was studied. No reduction of DOX into DOXOL was detected. Nevertheless, the involvement in reduction of DAUN into DAUNOL as well as IDA into IDAOL was demonstrated. The kinetic values obtained were then compared with data which have already been reported for cytosolic ANTs reductases.
650    _2
$a alkoholoxidoreduktasy $x metabolismus $7 D000429
650    _2
$a antracykliny $x metabolismus $7 D018943
650    _2
$a protinádorové látky $x metabolismus $7 D000970
650    _2
$a biotransformace $7 D001711
650    _2
$a buněčná membrána $x enzymologie $x metabolismus $7 D002462
650    _2
$a lidé $7 D006801
650    _2
$a jaterní mikrozomy $x enzymologie $x metabolismus $7 D008862
650    _2
$a substrátová specifita $7 D013379
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Skarydová, Lucie
700    1_
$a Stambergová, Hana
700    1_
$a Wsól, Vladimír
773    0_
$w MED00002111 $t Chemico-biological interactions $x 1872-7786 $g Roč. 191, č. 1-3 (2011), s. 66-74
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21185270 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20121207104757 $b ABA008
999    __
$a ok $b bmc $g 949945 $s 785249
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 191 $c 1-3 $d 66-74 $i 1872-7786 $m Chemico-biological interactions $n Chem Biol Interact $x MED00002111
LZP    __
$a Pubmed-20120817/11/03

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...